Localization studies in persistent or recurrent hyperparathyroidism

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 430-438

  Rodriguez, Jose M ^a,b   Parrilla, P ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747355814     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50050-8     Document Type: Chapter

References (121)

1. Levin KE, Gooding GAW, Okerlund M, et al. Localization studies in patients with a persistent or recurrent hyperparathyroidism. Surgery 1987, 102:917.
2. Thompson NW Localization studies in patients with primary hyperparathyroidism. Br J Surg 1988, 75:97.
3. Auguste LJ, Attie JN, Schanap D Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg 1990, 160:333.
4. Clark OH, Wilkes W, Siperstein AE, et al. Diagnosis and management of asymptomatic hyperparathyroidism: Safety, efficacy, and deficiencies in our knowledge. J Bone Miner Res 1991, 6:25.
5. Lundgren E, Rastad J, Ridefelt P, et al. Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. Surgery 1992, 112:1123.
6. Uden P, Chan AK, Duh QY, et al. Primary hyperparathyroidism in younger and older patients: Clinical symptoms and outcome of surgery. World J Surg 1992, 16:791.
7. Kjellman M, Sandelin K, Farnebo LO Primary hyperparathyroidism: Low surgical morbidity supports liberal attitude to operation. Arch Surg 1994, 129:237.
8. Sosa JA, Powe NR, Levine MA, et al. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: A national survey of endocrine surgeons. J Clin Endocrinol Metab 1998, 83:2658.
9. Brennan ME, Norton JA Reoperation for persistent and recurrent hyperparathyroidism. Ann Surg 1985, 120:40.
10. Grant CS, Van Heerden JA, Charboneau EM, et al. Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg 1986, 10:555.
11. Carty SE, Norton JA Management of patients with persistent or recurrent primary hyperparathyroidism. World J Surg 1991, 15:716.
12. Jarhült J, Nordeström J, Perbeck L Reoperation for suspected primary hyperparathyroidism. Br J Surg 1993, 80:453.
13. Shen W, Düren M, Morita E, et al. Reoperation for persistent and recurrent primary hyperparathyroidism. Arch Surg 1996, 131:861.
14. Wells SA, Debenedetti MK, Doherty GM Recurrent or persistent hyperparathyroidism. J Bone Miner Res 2002, 17:158.
15. Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 1996, 224:308.
16. Hasse C, Sitter H, Brunne M, et al. Quality of life and patient satisfaction after reoperation for primary hyperparathyroidism: Analysis of long-term results. World J Surg 2002, 13:26.
17. Tezelman S, Shen W, Shaver JK, et al. Double parathyroid adenomas: Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 1993, 218:300.
18. Kebebew E, Arici C, Duh QD, Clark OH Localization and reoperations results for persistent and recurrent parathyroid carcinoma. Arch Surg 2001, 136:878.
19. Wang C-A The anatomic basis of parathyroid surgery. Ann Surg 1976, 183:271.
20. Liechtty RD Parathyroid anatomy in hyperplasia. Arch Surg 1992, 127:813.
21. Henry JF, Denizot A, Audiffret J, France G Results of reoperations for persistent or recurrent secondary hyperparathyroidism in hemodialysis patients. World J Surg 1990, 14:303.
22. Fraker DL, Doppman JL, Shwaker TH, et al. Undescended parathyroid: An important etiology for failed operations for primary hyperparathyroidism. World J Surg 1990, 14:342.
23. Conn JM, Gongalves MA, Mansour KA, McGarity WC The mediastinal parathyroid. Am Surg 1991, 57:62.
24. Patow CA, Norton JA, Bennan ME Vocal paralysis and reoperative parathyroidectomy: A prospective study. Ann Surg 1986, 203:282.
25. Roe SM, Burns P, Graham LD, et al. Cost effectiveness of preoperative localization studies in primary hyperparathyroidism disease. Ann Surg 1994, 219:582.
26. Wyman SM, Robbins LL The roentgen recognition of parathyroid adenoma. AJR Am J Roentgenol 1954, 71:777.
27. Stevens AC, Jackson CE Localization of parathyroid adenoma by oesophageal cineroentgenography. AJR Am J Roentgenol 1967, 99:223.
28. Samuels BJ, Dowdy AH, Lecky JW Parathyroid termography. Radiology 1972, 104:575.
29. Edis AJ, Evans PC High-resolution real-time ultrasonography and preoperative localization of parathyroid tumors. N Engl J Med 1979, 301:532.
30. Levin K, Clark OH The reasons of failure in parathyroid surgery. Arch Surg 1989, 124:911.
31. Liburty SK, Bartlett DL, Jaskowiak NT, et al. The role of the thyroid resection during reoperation for persistent or recurrent hyperparathyroidism. Surgery 1997, 122:1183.
32. Mclntyre RC, Eisenach JH, Pearlman NW, et al. Intrathyroidal parathyroid glands can be a cause of failed cervical exploration for hyperparathyroidism. Am J Surg 1997, 174:750.
33. Gooding GAW Sonography of the thyroid and parathyroid. Radiol Clin North Am 1993, 31:967.
34. Erdman WA, Breslav NA, Weinreb JC, et al. Noninvasive localization of parathyroid adenomas: A comparison of x-ray, computerized tomography, ultrasound, scintigraphy, and MR1. Magn Reson Imaging 1989, 102:917.
35. Kurbskack AJ, Wilson SD, Lawson TL, et al. Prospective comparison of radionuclide, computed tomography, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 1989, 106:639.
36. Miller DL, Doppman JL, Shawker TH, et al. Localization of parathyroid adenomas in patients who have undergone surgery: I. Noninvasive imaging methods. Radiology 1987, 162:133.
37. Rodriguez JM, Tezelman S, Siperstein AE, et al. Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 1994, 129:870.
38. Numerow LM, Morita ET, Clark OH, et al. Persistent/recurrent hyperparathyroidism: A comparison of sestamibi scintigraphy, MRI and ultrasonography. J Magn Res Imaging 1995, 5:702.
39. Peeler BB, Martin WH, Sandler MP, Goldstein RE Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: Development of an optimal localization. Am Surg 1997, 63:37.
40. Thompson JB, Grant CS, Perrier ND, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 1999, 134:699.
41. 99mTc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000, 214:393.
42. Feingold DL, Alexander HR, Chen CC, et al. Ultrasound and sestamibi scan as the only preoperative imaging test in reoperation for parathyroid adenomas. Surgery 2000, 128:1103.
43. Carlson GL, Farndon GL, Clayton B, Rose PG Thallium isotope scintigraphy and ultrasonography: Comparative studies of localization techniques in primary hyperparathyroidism. Br J Surg 1990, 77:327.
44. Henry JF, Audifret J, Denizot A Endosonography in the localization of parathyroid tumours: A preliminary study. Surgery 1990, 108:1021.
45. Catargi B, Raymond JM, Lafarge-Gense V, et al. Localization of parathyroid tumours using endoscopic ultrasonography in primary hyperparathyroidism. J. Endocrinol Invest 1999, 22:688.
46. Gooding GAW, Clark OH Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions. Am J Surg 1992, 164:51.
47. Kohri K, Ishikawa Y, Mitsumasa K, et al. Comparison of imaging methods for localization of parathyroids tumors. Am J Surg 1992, 164:140.
48. Auffermann W, Gooding GAW, Okerlund MD, et al. Diagnosis of recurrent hyperparathyroidism: Comparison of MR imaging and the other techniques. AJR Am J Roentgenol 1988, 150:1027.
49. Doherty GM, Doppman JL, Miller DL, et al. Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent hyperparathyroidism. Ann Surg 1992, 215:101.
50. Mariette C, Pelliser L, Combemale F, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbecks Arch Surg 1998, 383:174.
51. Kem KA, Shawker TH, Jones BL Intraoperative ultrasound on reoperative parathyroid surgery: An initial evaluation. World J Surg 1986, 10:631.
52. Aufferman W, Guis M, Tavares NJ, Higgins CB MR signal intensity of parathyroid adenomas: Correlation with histopamology. AJR Am J Roentgenol 1989, 153:873.
53. Higgins CB Role of magnetic resonance imaging in hyperparathyroidism. Radiol Clin North Am 1993, 31:1017.
54. Fayet C, Hoeffel C, Fulla Y, et al. Technetium-99m sestamibi scintigraphy, magnetic resonance imaging, and venous sampling in persistent and recurrent hyperparathyroidism. Br J Radiol 1998, 71:108.
55. 99mTc-MIBl scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism. Radiology 2001, 218:783.
56. Higgins CB, Aufferman W MRI imaging of thyroid and parathyroid: A review of current status. AJR Am J Roentgenol 1988, 151:1095.
57. Ishibashi M, Nishida H, Hiromatsu Y, et al. Comparison of technetium-99m-MIBI, technetium 99m-tetrofosmin, ultrasound, and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998, 39:320.
58. McDermott VG, Fernandez RJM, Meaken TJ, et al. Preoperative MR imaging in hyperparathyroidism: Results and factors affecting parathyroid detection. AJR Am J Roentgenol 1996, 166:705.
59. Seelos KC, De Marco R, Clark OH, Higgins CB Persistent and recurrent hyperparathyroidism assessment with gadopentetate dimeglumineenhanced MR imaging. Radiology 1990, 177:373.
60. Kang YS, Resen K, Clark OH, Higgins CB Localization of abnormal parathyroid glands of the mediastinum with MR imaging. Radiology 1993, 189:137.
61. 201T1 chloride in a parathyroid adenoma. Clin Nucl Med 1979, 4:229.
62. Ferlin G, Borsato N, Camerani M, et al. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med 1983, 24:438.
63. Young AE, Gaunt JI, Croft DN, et al. Localization of parathyroid adenomas by thallium 201 and technetium 99m. BMJ 1983, 286:1384.
64. Chan TY, Serpell JW, Chan O, et al. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy. Br J Radiol 1991, 64:1.
65. Attie JN, Khan A, Rumanck WM, et al. Preoperative localization of parathyroid adenomas. Am J Surg 1988, 156:323.
66. Price DC Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am 1993, 31:991.
67. Coakley AJ, Kettle AG, Wells CP, et al. 99m-Technetium sestamibi: A new agent for parathyroid imaging. Nucl Med Commun 1989, 10:791.
68. Chiu ML, Kronange JF, Piwnica Worms D Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxy-isobutylisonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990, 31:1646.
69. Sandrock D, Merino MJ, Norton JA, et al. Light and electromicroscopic analyses of parathyroid tumours explain results of T1201 Tc99m parathyroid scintigraphy. Eur J Med 1989, 15:410.
70. O'Doherty MJ, Kettle AG, Collins REC, Coakley AJ Parathyroid imaging with technetium 99m sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 1992, 33:313.
71. Mitchel BK, Cornelius EA, Zoghbi S, et al. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 1996, 120:1039.
72. Piñero A, Rodriguez JM, Martinez-Barba E, et al. Tc-99m sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: A causal or casual relationship?. Surgery 2003, 134:41.
73. Taillefer R, Boucher Y, Potvin C, Lambert R Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium 99m sestamibi (double-phase study). J Nucl Med 1992, 33:1801.
74. Wei JP, Burke GJ, Mansberger AR Prospective evaluation of the efficiency of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992, 112:1111.
75. Wei JP, Burke GJ, Mansberger AD Prospective imaging of abnormal parathyroid glands in patients with hyperparathyroidism disease using combination Tc99m-pertechnetate and Tc99m sestamibi radionuclide scans. Ann Surg 1994, 219:568.
76. Hindié E, Melliere D, Simon D, Perlemuter L, et al. Primary hyperparathyroidism: Is technetium 99m sestamibi/iodine subtraction scanning the best procedure to locate enlarged glands before surgery?. J Clin Endocrinol Metab 1995, 80:302.
77. Chen CC, Skarulis MC, Fraker DL, et al. Technetium-99m sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med 1995, 36:2186.
78. Jeanguillaume C, Hindié E, Meignan-Debray S, et al. Tc-99m sestamibi and I-123 detection of a parathyroid adenoma in the presence of cold thyroid nodule. Clin Nucl Med 1997, 22:258.
79. Sfakianakis GN, Irvin GL III, Foss J, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996, 88:798.
80. Neumann DR, Esselstyn CB, Kim EY, et al. Primary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism. Clin Nucl Med 1997, 22:217.
81. Chen CC, Holder LE, Scovill WA, et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m sestamibi and technetium-99m sestamibi SPECT. J Nucl Med 1997, 38:834.
82. Teigen EL, Kilgore EJ, Cowan RJ, et al. Technetium-99m sestamibi SPECT localization of mediastinal parathyroid adenomas. J Nucl Med 1996, 37:1535.
83. Irvin GL, Molinari AS, Figueroa C, et al. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 1999, 229:874.
84. Pattou F, Huglo D, Proye C Radionuclide scanning in parathyroid diseases. Br J Surg 1998, 85:1605.
85. Piñero A, Rodriguez JM, Ortiz S, et al. Influence of thyroid pathology on the results of parathyroid gammagraphy with Tc99m sestamibi. Clin Endocrinol 2000, 53:655.
86. Koss WGM, Brown MR, Balfour JF A false-positive localization of parathyroid adenoma with technetium Tc99m sestamibi scan secondary to a thyroid follicular carcinoma. Arch Surg 1996, 131:216.
87. Nakahara H, Noguchi S, Murakami N, et al. Technetium-99m sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumours. J Nucl Med 1996, 37:901.
88. Balon HR, Fink-Bennet D, Staffer SS Technetium-99m sestamibi uptake by recurrent Hürthle cell carcinoma of the thyroid. J Nucl Med 1992, 33:1393.
89. Scott AM, Kostakoglu L, O'Brien JP, et al. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992, 33:1396.
90. Aigner RM, Fueger GF, Nicoletti R Parathyroid scintigraphy: Comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m-tetrophosmin studies. Eur J Nucl Med 1996, 23:693.
91. Pattou F, Oudar C, Huglo D, et al. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrophosmin. Aust N Z J Surg 1998, 68:108.
92. Ishibashi M, Nishida H, Strauss W, et al. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging. J Nucl Med 1997, 38:706.
93. Pattou F, Huglo D, Proye C Radionuclide scanning in parathyroid disease. Br J Surg 1998, 85:1605.
94. Giordano A, Meduri G, Rubini G, et al. Italian multicenter study on 99m-Tc-tetrophosmin in parathyroid scintigraphy: Results in 133 subjects. Eur J Nucl Med 1998, 25:9.
95. Aigner RM, Fueger GF, Wolf G Parathyroid scintigraphy: First experiences with technetium(III)-99m-Q12. Eur J Nucl Med 1997, 24:326.
96. Arslan N, Rydzewski B Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography. Clin Nucl Med 2002, 27:221.
97. Neumann DR, Esselstyn CB, MacIntyre WJ, et al. Regional body FDG-PET in postoperative recurrent hyperparathyroidism. J Comput Assist Tomogr 1997, 21:25.
98. 11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 1998, 139:195.
99. Marcocci C, Mazzeo S, Bruno-Bossio G, et al. Preoperative localization of suspicious parathyroid adenomas by PTU assay in the needle aspiration. Eur J Endocrinol 1998, 139:72.
100. Tikkakosky T, Stenfors LE, Typpo T, et al. Parathyroid adenomas: Preoperative localization with ultrasound combined with fine-needle biopsy. J Laryngol Otol 1989, 62:981.
101. Karstrup S, Glenthoj A, Hainau B, et al. Ultrasound-guided, histological, fine-needle biopsy from suspect parathyroid tumours: Success rate and reliability of histological diagnosis. Br J Radiol 1989, 62:981.
102. McFarlane MP, Fraker DL, Shawker TH, et al. Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism. Surgery 1994, 116:959.
103. Miller DL Preoperative localization and interventional treatment of parathyroid tumours. When and how? World J Surg 1991, 15:706.
104. McIntyre RC, Kumpc DA, Liechty D Reexploration and angiographic ablution for hyperparathyroidism. Arch Surg 1994, 129:499.
105. Miller DL Endocrine angiography and venous sampling. Radiol Clin North Am 1993, 31:1051.
106. Nilsson BH, Tissell LK, Janson S, et al. Parathyroid localization hy catheterization of large cervical and mediastinal veins to determine serum concentrations of intact parathyroid hormone. World Surg 1994, 18:605.
107. Sugg SL, Fraker DL, Alexander R, et al. Prospective evaluation of selective venous sampling for parathyroid hormone concentrations in patients undergoing reoperations for primary hyperparathyroidism. Surgery 1993, 114:1004.
108. Billingsley KG, Fraker DL, Doppman JL, et al. Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism. Surgery 1994, 116:982.
109. Jones JJ, Brunaud L, Dowd CF, et al. Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 2002, 132:944.
110. Casanova D, Safati E, De Francisco A, et al. Secondary hyperparathyroidism: Diagnosis of site of recurrence. World J Surg 1991, 15:546.
111. Demeter JG, De Jong SA, Lawrence AM, Paloyan E Recurrent hyperparathyroidism due to parathyroid autografts: Incidence, presentation, and management. Am Surg 1993, 59:178.
112. Fong-Fu C, Chiang Hsuan L, Hue-Yon C, et al. Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann Surg 2002, 235:99.
113. Alexander HR, Chen CC, Shawker T, et al. Role of preoperative localization manoeuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism. J Bone Miner Res 2002, 17:133.
114. Norman JG, Jaffray CE, Chheda H The false-positive parathyroid sestamibi: A real or perceived problem and a case for radio-guided parathyroidectomy. Ann Surg 2000, 231:31.
115. Huang GU, Wu HS, Tsai SC, et al. Recurrent hyperfunctioning parathyroid gland demonstrated radionuclide imaging and an intraoperative gamma probe. Clin Nucl Med 2000, 25:348.
116. 99mTc sestamihi in primary and recurrent hyperparathyroidism.]. Chirurg 2001, 72:1179.
117. Navarra G, Feggi L, Ascanelli S, et al. Role of radio-guided surgery in recurrent secondary hyperparathyroidism. Nephron 2001, 88:36.
118. Prove CA, Goropoulos A, Franz C, et al. Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: Sequential measurements in patients with multiglandular disease. Surgery 1991, 110:1035.
119. Irvin GL III, Prudhomme BS, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg 1994, 219:574.
120. Irvin GL III, Dembrow VD, Prudhomme DL Clinical usefulness of an intraoperative "quick parathyroid hormone" assay. Surgery 1993, 114:1019.
121. Irvin GL, Molinari AS, Figueroa C, Carneiro DM Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 1999, 226:874.